Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2015 2
2016 2
2017 3
2018 8
2019 4
2020 2
2021 8
2022 16
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer.
Singh S, Lee N, Pedroza DA, Bado IL, Hamor C, Zhang L, Aguirre S, Hu J, Shen Y, Xu Y, Gao Y, Zhao N, Chen SH, Wan YW, Liu Z, Chang JT, Hollern D, Perou CM, Zhang XHF, Rosen JM. Singh S, et al. Among authors: xu y. Cancer Res. 2022 Jun 15;82(12):2281-2297. doi: 10.1158/0008-5472.CAN-21-3714. Cancer Res. 2022. PMID: 35442423 Free PMC article.
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.
Mai S, Hodges A, Chen HM, Zhang J, Wang YL, Liu Y, Nakatsu F, Wang X, Fang J, Xu Y, Davidov V, Kang K, Pingali SR, Ganguly S, Suzuki M, Konopleva M, Prinzing B, Zu Y, Gottschalk S, Lu Y, Chen SH, Pan PY. Mai S, et al. Among authors: xu y. Cancer Res. 2023 Dec 15;83(24):4047-4062. doi: 10.1158/0008-5472.CAN-22-2483. Cancer Res. 2023. PMID: 38098451
Aerosolized miR-138-5p and miR-200c targets PD-L1 for lung cancer prevention.
Zhang Q, Pan J, Xiong D, Zheng J, McPherson KN, Lee S, Huang M, Xu Y, Chen SH, Wang Y, Hildebrandt Ruiz L, You M. Zhang Q, et al. Among authors: xu y. Front Immunol. 2023 Jul 13;14:1166951. doi: 10.3389/fimmu.2023.1166951. eCollection 2023. Front Immunol. 2023. PMID: 37520581 Free PMC article.
Virus-Mimic mRNA Vaccine for Cancer Treatment.
Meng C, Chen Z, Mai J, Shi Q, Tian S, Hinkle L, Li J, Zhang Z, Ramirez M, Zhang L, Xu Y, Zhang J, Pan PY, Chen SH, Li H, Shen H. Meng C, et al. Among authors: xu y. Adv Ther (Weinh). 2021 Nov;4(11):2100144. doi: 10.1002/adtp.202100144. Epub 2021 Sep 17. Adv Ther (Weinh). 2021. PMID: 34901386 Free PMC article.
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.
Sun K, Xu Y, Zhang L, Niravath P, Darcourt J, Patel T, Teh BS, Farach AM, Guerrero C, Mathur S, Sultenfuss MA, Gupta N, Schwartz MR, Haley SL, Nair S, Li X, Nguyen TTA, Butner JD, Ensor J, Mejia JA, Mei Z, Butler EB, Chen SH, Bernicker EH, Chang JC. Sun K, et al. Among authors: xu y. Clin Cancer Res. 2022 Oct 14;28(20):4392-4401. doi: 10.1158/1078-0432.CCR-22-0622. Clin Cancer Res. 2022. PMID: 35877117 Free PMC article. Clinical Trial.
53 results